Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

companion diagnostics

This page shows the latest companion diagnostics news and features for those working in and with pharma, biotech and healthcare.

Relics from the past

Relics from the past

There were people who developed drug-delivery systems. There were others who sold companion diagnostics. ... And, if not genotype-specific, many treatments are guided by companion diagnostics looking for biomarkers.

Latest news

  • Edging Evolution Edging Evolution

    Value created beyond the pill, such as companion diagnostics and devices, are good examples of environmental selection, while me-too products that are not granted market access illustrate the market disfavouring

  • Lynparza could soon add first line ovarian use in Europe Lynparza could soon add first line ovarian use in Europe

    As with other ‘personalised medicine’ drugs, the company’s commercial division is aiming to maximise uptake by broadening access to companion diagnostics which can identify BRCA mutations in patients across these

  • Gradually, then suddenly Gradually, then suddenly

    The second kept on looking for whole-disease area blockbusters long after companion diagnostics had fractured its market.

  • Roche agrees $2.4bn takeover of genomics player Foundation Roche agrees $2.4bn takeover of genomics player Foundation

    Prior to the approval of F1CDx, most companion diagnostics for cancer matched one test to one drug, but the FDA said that using Foundation’s test could identify which patients with ... There has also been movement at the federal level in the US, with

  • Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more

    Foundation Medicine is a major player in the emerging field of next generation cancer diagnostics and genomic profiling, and two developments yesterday confirmed it as a leader in what will undoubtedly ... If approved, this test could be the

More from news
Approximately 3 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    companion diagnostics.

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Diagnostics and cracking the market access code. For many of the company’s new generation of treatments, the uptake of companion diagnostics into routine clinical practice is another part of the ... Reic said the adoption of diagnostics into standard

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    The response has been a surge of interest in developing novel companion biomarkers, and biomarkers that allow personalisation of therapy. ... FDA is stimulating this approach and one can see the development of, for instance, TMB assays, targeted gene

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    9. RUTH MARCH. Precision medicine leader. Precision medicine and the use of companion diagnostics now plays a fully integrated role in many successful new cancer therapies. ... But how do you deliver these companion diagnostics to healthcare systems and

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    This encompasses approaches to detecting cancers earlier, including novel techniques such as liquid biopsies (aka circulating tumour DNA tests) and new companion diagnostics.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Dr Holger Adelmann joins DIA EMEA Dr Holger Adelmann joins DIA EMEA

    In that role he oversaw the reengineering of its clinical biomarker and companion diagnostics business to align with upcoming portfolio demands.

  • FlowMetric Diagnostics names president FlowMetric Diagnostics names president

    FlowMetric Diagnostics, a provider of flow cytometry and cell sorting services, has appointed Amy Williams as its president. ... It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised

  • Roche appoints new oncology research head Roche appoints new oncology research head

    Commenting on Pao's appointment, Reed said: "William is recognised as one of the world's leading molecular oncologists, with world class expertise in targeted cancer therapeutics, translational medicine, molecular diagnostics, ... diagnostics company,

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    Novartis and Roche are two champions of personalised medicine, shaping the area with the launch of targeted treatments combined with a companion diagnostic to support patient identification. ... approval of their new  FoundationOne CDx, the first and

  • Excellence in oncology: Developing an effective biomarker strategy

    Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.

  • Research Partnership

    Medical devices and diagnostics. Our experience covers everything from insulin pens to large-scale surgical systems. ... Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Quick links

Infographics

Multimedia